A

AstraZeneca PLC
NASDAQ:AZN

Watchlist Manager
AstraZeneca PLC
NASDAQ:AZN
Watchlist
Price: 78.02 USD -0.37% Market Closed
Market Cap: 241.9B USD
Have any thoughts about
AstraZeneca PLC?
Write Note

AstraZeneca PLC
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

AstraZeneca PLC
Operating Expenses Peer Comparison

Comparables:
G
GSK
INDV
HIK
DPH
A
APH

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
A
AstraZeneca PLC
NASDAQ:AZN
Operating Expenses
-$30.1B
CAGR 3-Years
-18%
CAGR 5-Years
-16%
CAGR 10-Years
-5%
G
GlaxoSmithKline PLC
NYSE:GSK
Operating Expenses
-ÂŁ15.3B
CAGR 3-Years
-4%
CAGR 5-Years
-2%
CAGR 10-Years
-3%
Indivior PLC
LSE:INDV
Operating Expenses
-$688m
CAGR 3-Years
-20%
CAGR 5-Years
-8%
CAGR 10-Years
-5%
Hikma Pharmaceuticals PLC
LSE:HIK
Operating Expenses
-$813m
CAGR 3-Years
-6%
CAGR 5-Years
-5%
CAGR 10-Years
-7%
Dechra Pharmaceuticals PLC
LSE:DPH
Operating Expenses
-ÂŁ404.7m
CAGR 3-Years
-20%
CAGR 5-Years
-17%
CAGR 10-Years
-17%
A
Alliance Pharma PLC
LSE:APH
Operating Expenses
-ÂŁ68m
CAGR 3-Years
-3%
CAGR 5-Years
-8%
CAGR 10-Years
-17%

See Also

What is AstraZeneca PLC's Operating Expenses?
Operating Expenses
-30.1B USD

Based on the financial report for Jun 30, 2024, AstraZeneca PLC's Operating Expenses amounts to -30.1B USD.

What is AstraZeneca PLC's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-5%

Over the last year, the Operating Expenses growth was -11%. The average annual Operating Expenses growth rates for AstraZeneca PLC have been -18% over the past three years , -16% over the past five years , and -5% over the past ten years .

Back to Top